[go: up one dir, main page]

CN112175889A - A high-yielding vitamin K2 strain and its application - Google Patents

A high-yielding vitamin K2 strain and its application Download PDF

Info

Publication number
CN112175889A
CN112175889A CN202011249346.7A CN202011249346A CN112175889A CN 112175889 A CN112175889 A CN 112175889A CN 202011249346 A CN202011249346 A CN 202011249346A CN 112175889 A CN112175889 A CN 112175889A
Authority
CN
China
Prior art keywords
strain
fermentation
application according
vitamin
seed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011249346.7A
Other languages
Chinese (zh)
Other versions
CN112175889B (en
Inventor
任路静
彭程
胡学超
卢健尧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Yingyangxing Biotechnology Co ltd
Original Assignee
Nanjing Tech University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Tech University filed Critical Nanjing Tech University
Priority to CN202011249346.7A priority Critical patent/CN112175889B/en
Publication of CN112175889A publication Critical patent/CN112175889A/en
Application granted granted Critical
Publication of CN112175889B publication Critical patent/CN112175889B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus
    • C12R2001/125Bacillus subtilis ; Hay bacillus; Grass bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/66Preparation of oxygen-containing organic compounds containing the quinoid structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

本发明公开了一株高产维生素K2的菌株及其应用,所述菌株分类命名为Bacillus subtilis ALE‑Gly,保藏编号为GDMCC No:61234。本发明利用含有抑制剂的培养基驯化原始菌株,在含有草甘膦的种子培养基中传代培养,然后在普通种子培养基中恢复培养,获得驯化菌株。驯化后的菌株经发酵,维生素K2产量、生物量、产率分别比原始菌株提高了4倍,2倍,2.4倍左右,同时驯化菌株产芽孢的时间推迟24小时,EPSP合酶的酶活性提高了2‑3倍,且氮源利用率高,发酵时间较原始菌株缩短,降低了生产成本。

Figure 202011249346

The invention discloses a high-yield vitamin K2 strain and its application. The strain is classified and named Bacillus subtilis ALE-Gly, and the preservation number is GDMCC No: 61234. The invention utilizes the medium containing the inhibitor to domesticate the original strain, subcultures it in the seed medium containing glyphosate, and then restores the culture in the common seed medium to obtain the domesticated strain. The domesticated strains were fermented, and the vitamin K2 production, biomass and yield were increased by 4 times, 2 times, and 2.4 times, respectively, compared with the original strains. At the same time, the spore-forming time of the domesticated strains was delayed by 24 hours, and the enzyme activity of EPSP synthase was improved. Compared with the original strain, the fermentation time is shortened, and the production cost is reduced.

Figure 202011249346

Description

Strain capable of highly producing vitamin K2 and application thereof
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a strain for highly producing vitamin K2 and application thereof.
Background
Menaquinones (MK), also called vitamin K2, is a trace fat-soluble vitamin produced by probiotic flora in human intestinal tract, is a general name of a group of substances containing 2-methyl-1, 4-naphthoquinone ring, has phylloquinone bioactivity, is one of essential vitamins in human body, is an important fat-soluble blood coagulation vitamin, and mainly has the function of
Figure 887890DEST_PATH_IMAGE001
Preventing and treating osteoporosis.
Figure DEST_PATH_IMAGE002
Preventing artery calcification and osteoarthritis.
Figure 8293DEST_PATH_IMAGE003
And (3) resisting tumors.
Figure DEST_PATH_IMAGE004
Delaying senility
Figure 991292DEST_PATH_IMAGE005
Repairing damaged cells and potentially treating the Parkinson's disease. The safety of the drug is determined by the authorities of the food and drug administration, the drug research institute and the European parliament and the European Union council. The natural menadione with higher activity can be obtained only by a microbial fermentation method, so the microbial fermentation method is concerned by scholars at home and abroad and has wide application prospect. The bacillus natto belongs to subspecies of bacillus subtilis, and has the advantages of safety, high growth speed, short fermentation period, easy culture, high menadione content and the like, so that the bacillus natto is the most main microorganism for preparing menadione by fermentation at present, and the product of the bacillus natto is mainly menadione-7 (MK-7).
Currently, most researchers mainly utilize bacillus natto to directly ferment and produce vitamin K2 or construct a metabolic pathway of vitamin K2 in bacillus subtilis to produce vitamin K. The prior art about the production of vitamin K2 by fermentation of Bacillus mainly comprises: mutation breeding of a VK2 production strain; 2. optimized with respect to medium composition. The traditional fermentation regulation and control process is difficult to stably control, and the fermentation regulation and control mainly changes the components of a culture medium or culture conditions, so that the performance of the strain is not fundamentally optimized. The traditional strain transformation mainly adopts a mutagenesis screening method, but the screening work is blind due to the lack of a screening way aiming at the strain with high VK2 content, so the strain screening workload is large, and the screening effect is not ideal. Therefore, the new strain performance improvement method has important significance for improving the fermentation content of VK 2.
Disclosure of Invention
Aiming at the technical problem of relative blindness in the strain breeding process in the prior art, the technology obtains a strain with high vitamin K2 yield by an oriented domestication method.
In order to achieve the technical purpose, the invention adopts the following technical scheme:
strain capable of producing vitamin K2 with high yield, and its classification name isBacillus subtilis ALE-Gly with the deposit number GDMCC No: 61234.
the invention obtains a high-yield strain of vitamin K2 by an acclimatization method, adds a chemical reagent of glyphosate into an acclimatization culture medium, cultures bacillus natto in the culture medium containing the glyphosate for acclimatization, and screens out the ALE-Gly strain.
The invention also aims to provide application of the strain in fermentation production of VK2, wherein the strain is subjected to seed culture and fermentation culture to obtain a product.
Further, the seed culture mode is as follows: inoculating the strain to a seed culture medium for activation culture in an inoculation amount of 1% (V/V), and performing two-generation activation;
further, the conditions for activating each generation of seeds were 12 h, 37 ℃ and 200 rpm.
Further, the culture medium for seed culture comprises the following components: 30-60 g/L of glucose, 10-15 g/L of tryptone, 5-7 g/L of NaCl and 5-7 g/L of yeast powder.
Further, the components of a culture medium for fermentation culture are as follows: soybean peptone 60-100 g/L, glycerin 30-60 g/L, yeast powder 0.6-0.8 g/L, K2HPO4·3H2O 6.55~8.55 g/L,MgSO4·7H20.3-0.5 g/L of O and anhydrous CaCl2 0.0775~0.0975 g/L。
Further, adding a small molecule compound into a fermentation medium; the small molecular compound is selected from pyruvic acid, shikimic acid and sodium glutamate;
furthermore, the addition concentration of the small molecular compound is 2-4 g/L of pyruvic acid, 2-10 g/L of shikimic acid and 10-15 g/L of sodium glutamate. .
Furthermore, 4 g/L pyruvic acid, 4 g/L shikimic acid and 15 g/L sodium glutamate are added into the fermentation medium at the same time.
The invention has the beneficial effects that:
(1) the invention obtains a high-yield VK2 strain through a brand-new idea and method for domesticating and transforming strains, the domestication process does not relate to a genetic engineering method, and the domestication process is carried out for multiple generations by simply using an inhibitor of key enzyme in a biosynthetic metabolic pathway of vitamin K2. The method is environment-friendly, simple and convenient, and has no increase in manpower and material resources.
The technical principle of acclimatization may be that EPSP synthase is a key enzyme in metabolic pathway of synthesizing VK2 by bacillus, glyphosate is an inhibitor, if the strain grows in a seed culture medium containing glyphosate, the activity of EPSP synthase is improved in order to resist the poison of glyphosate, VK2 is an important electron transfer carrier in an oxygen breathing electron transfer chain, and enough VK2 must be synthesized to resist the severe environment in order to successfully carry out oxygen breathing. Only strains with high EPSP synthase activity can survive in the environment, and therefore, the method also plays a role in screening high-yield bacteria of VK 2.
(2) The strain obtained by domestication has vigorous growth in a normal culture medium, the carbon and nitrogen source consumption speed is accelerated, the fermentation period is short, the maximum yield is basically reached within 72 hours, the spore generation time is delayed for 24 hours, the biomass is 2 times higher than the original biomass, the VK2 yield is 4 times higher than the original yield, the EPSP synthase activity is enhanced by 2-3 times, the nitrogen source utilization rate is high, the domesticated strain has stable physiological and biochemical conditions and stable genetic performance, continuous passage is carried out for 5 times, the fermentation produced vitamin K2 is at a higher level, and the domesticated strain is an excellent strain with high vitamin K2 yield.
(3) The fermentation culture process is optimized, and pyruvic acid, shikimic acid and sodium glutamate are added into the fermentation culture medium, so that the yield of VK2 is improved.
Drawings
FIG. 1 is a graph showing the results of genetic stability of the acclimatized strain.
FIG. 2 shows MK-7 yields from fermentation of original A13 and domesticated ALE-40 (i.e., ALE-Gly) supplemented with different concentrations of small molecule compounds (shikimic acid, pyruvic acid, sodium glutamate).
FIG. 3 is a microscopic image of A13 and ALE-40 (i.e., ALE-Gly) fermentations.
The biological material of the invention is classified and namedBacillus subtilis ALE-Gly, which has been deposited in the Guangdong province culture Collection of microorganisms at 21.10.2020, with the deposit number GDMCC No: 61234, address: guangzhou city, first furious Zhonglu No. 100 large yard No. 59 building No. 5.
Detailed Description
The original strain related to the embodiment is obtained by laboratory self-screening, is disclosed in a patent CN104328064A previously applied in the laboratory, has a preservation number of CCTCC M2014405, and is named as Bacillus natto A13 in the embodiment.
Example 1
This example specifically illustrates the screening method of the strain of the present invention.
(1) Inoculating the original strain into seed culture medium at 1% (v/v) inoculation amount, culturing for 12 hr at 37 deg.C at 200 rpm to complete the first generation activation, and performing the second generation seed activation by the same method to obtain seed.
(2) Inoculating the activated strain into 5 mu mol/L glyphosate acclimatization culture medium with the inoculation amount of 1%, wherein the culture time is 12 hours, the rotation speed is 200 rpm, and the temperature is 37 ℃, and then completing the first generation acclimatization. And then, streaking the first generation of domesticated strains on a solid domesticated culture medium with the same concentration, then selecting a single colony with larger growth to be inoculated into the next domesticated culture medium (the concentration of glyphosate is 5 mu mol/L) with the same concentration of glyphosate, taking the single colony as the second generation, and repeating the steps in the same way to carry out five generations of domestication.
Seed culture medium: 30-60 g/L of glucose, 10-15 g/L of tryptone, 5-7 g/L of NaCl and 5-7 g/L of yeast powder.
Domestication culture medium: 30-60 g/L of glucose, 10-15 g/L of tryptone, 5-7 g/L of NaCl and 5-7 g/L of yeast powder; 5, 10, 15, 20, 25 mu mol/L glyphosate.
(3) After five generations of domestication is completed, the strain streaked and purified on the domestication plate is inoculated into a domestication culture medium with the next concentration of 10 mu mol/L glyphosate, the culture time is 12 hours, the rotating speed is 200 rpm, and the temperature is 37 ℃, thus completing the first generation of domestication. And then streaking the first generation of domesticated bacterial strain on a 10 mu mol/L glyphosate solid domesticated culture medium, then selecting a single bacterial colony to be inoculated into the next domesticated culture medium with the same glyphosate concentration, and carrying out fifth generation domestication by analogy.
(4) Until the acclimatization of three concentrations of 15, 20 and 25 mu mol/L is completed in sequence. When the strain can contain 25 mu moI & L-1When the glyphosate is normally grown in the domestication culture medium, domestication is continuously carried out for 40 generations, domesticated strains ALE-10, ALE-20, ALE-30 and ALE-40 obtained by domestication for 10 generations, 20 generations, 30 generations and 40 generations are inoculated into a normal culture medium without the glyphosate to recover the growth, and a subsequent fermentation experiment is carried out.
Example 2
This example illustrates the method of producing vitamin K2 by fermentation using Bacillus natto according to the present invention.
(1) Seed culture
The seed culture medium comprises the following components: 30-60 g/L of glucose, 10-15 g/L of tryptone, 5-7 g/L of NaCl and 5-7 g/L of yeast powder.
Inoculating the domesticated strain into a seed culture medium with the inoculation amount of 1%, culturing for 12 hours at the rotation speed of 200 r/min to complete first-generation activation, and performing second-generation seed activation by the same method to obtain seeds.
(2) Fermentation culture
Fermentation medium: soybean peptone 60-100 g/L, glycerin 30-60 g/L, yeast powder 0.6-0.8 g/L, K2HPO4·3H2O 0.3-0.6 g/L,MgSO4·7H20.3-0.5 g/L of O and anhydrous CaCl2 0.0775~0.0975 g/L。
Inoculating the seed liquid into a fermentation culture medium at an inoculation amount of 1-5% (v/v), wherein the fermentation temperature is 37 ℃, the rotation speed is 200 rpm, and the fermentation is stopped when the fermentation is carried out for 6 days.
Example 3
This example illustrates the shake flask fermentation performance comparison of acclimatized and original strains.
Strains domesticated in a glyphosate culture medium in different generations are selected, fermentation is carried out under normal conditions, and the fermentation performances (VK 2 production capacity) of the different domesticated strains and the original strains are compared under the normal culture medium.
The fermentation process in this example is as follows:
(1) seed culture
The seed culture medium comprises the following components: 30 g/L of glucose, 10 g/L of tryptone, 5 g/L of NaCl and 5 g/L of yeast powder.
Inoculating the domesticated strain into a seed culture medium with the inoculation amount of 1%, culturing for 12 hours at the rotation speed of 200 r/min to complete first-generation activation, and performing second-generation seed activation by the same method to obtain seeds.
(2) Fermentation culture
Fermentation medium: soybean peptone 90 g/L, glycerin 60 g/L, yeast powder 0.6 g/L, K2HPO4·3H2O 0.3 g/L,MgSO4·7H2O0.3 g/L, anhydrous CaCl2 0.08 g/L。
Inoculating the seed liquid into a fermentation culture medium at an inoculation amount of 1-5% (v/v), wherein the fermentation temperature is 37 ℃, the rotation speed is 200 rpm, and the fermentation is stopped when the fermentation is carried out for 6 days.
During the fermentation process, biomass, glycerol consumption, VK2 yield and the like are measured, and the yield after 72h fermentation tends to be stable and approaches to the maximum yield. The fermentation parameters of the different acclimatized and original strains are compared in table 1.
TABLE 1 comparison of fermentation parameters of original and acclimatized strains
Figure DEST_PATH_IMAGE006
The ALE-40 strain domesticated for 40 generations has the highest VK2 content and yield, and is preserved and named ALE-Gly.
Example 4
And (3) verifying the genetic stability of the domesticated strain Bacillus natto ALE-Gly.
The strain ALE-Gly is subjected to shake flask fermentation and continuous culture for 5 generations to detect the genetic stability of the strain ALE-Gly. The yield of VK2 was determined after fermentation using the original strain Bacillus natto A13 as a control. The results of the subculture experiments with the acclimatized strain are shown in FIG. 1. As can be seen from the figure, the strain ALE-Gly has no obvious influence on the fermentation level through passage, the VK2 production capacity is stable, and the same higher level is maintained, which indicates that the strain ALE-Gly has good genetic stability.
Example 5
Adding different precursor substances to strengthen VK2 for synthesis.
The precursor addition is carried out on the basis of shake flask fermentation in example 3, namely pyruvic acid, shikimic acid and sodium glutamate with different concentrations are added in the fermentation process of the original strain. The concentration of pyruvic acid is: 2, 4, 6, 8,10 g/L; the concentration of shikimic acid is: 2, 4, 6, 8,10 g/L; the concentration of sodium glutamate is as follows: 5, 10, 15, 20, 25 g/L, the fermentation temperature is 37 ℃, and the rotation speed is 200 rpm. The final fermentation results are shown in Table 2, and the highest yield of VK2 in fermentation medium supplemented with 4 g/L pyruvic acid, 4 g/L shikimic acid and 15 g/L sodium glutamate of original bacteria A13 is 50, 48 and 38 mg/L respectively.
TABLE 2 precursor supply enhancement of the original strains
Figure 839031DEST_PATH_IMAGE007
Example 6
Influence of combined addition of precursor substances on VK2 production of different strains
Based on the optimal addition concentration of the precursor substances obtained in example 5, three precursor substances with corresponding concentrations, namely 4 g/L pyruvic acid, 4 g/L shikimic acid and 15 g/L sodium glutamate, are further added in the fermentation process of the original strain and the domesticated strain, and the fermentation results are shown in FIG. 2, wherein the maximum yield of VK2 of the original strain A13 and the domesticated strain ALE-Gly is 63 mg/L and 82 mg/L respectively.

Claims (10)

1.一株高产维生素K2的菌株,其特征在于,分类命名为Bacillus subtilis ALE-Gly,保藏编号为GDMCC No:61234。1. A high-yield vitamin K2 bacterial strain is characterized in that, the classification name is Bacillus subtilis ALE-Gly, and the deposit number is GDMCC No: 61234. 2.权利要求1所述纳豆芽孢杆菌在产维生素K2中的应用。2. the application of Bacillus natto described in claim 1 in producing vitamin K2. 3.根据权利要求2所述的应用,其特征在于,将所述菌株进行种子培养和发酵培养,获取产物。3. The application according to claim 2, wherein the bacterial strain is subjected to seed culture and fermentation culture to obtain a product. 4.根据权利要求3所述的应用,其特征在于,所述种子培养的方式为:将菌株以1%(V/V)接种量接种至种子培养基活化培养,进行两代活化。4 . The application according to claim 3 , wherein the seed cultivation method is as follows: inoculation of the bacterial strain with 1% (V/V) inoculation amount into the seed medium for activation and cultivation, and two generations of activation are carried out. 5 . 5. 根据权利要求4所述的应用,其特征在于,每代种子活化的条件为12 h, 37 ℃,200rpm。5. application according to claim 4, is characterized in that, the condition of each generation seed activation is 12 h, 37 ℃, 200rpm. 6. 根据权利要求3-4任一项所述的应用,其特征在于,种子培养的培养基成分为:葡萄糖30~60 g/L,胰蛋白胨 10~15 g/L,NaCl 5~7 g/L,酵母粉 5~7 g/L。6. application according to any one of claim 3-4 is characterized in that, the medium composition of seed culture is: glucose 30~60 g/L, tryptone 10~15 g/L, NaCl 5~7 g /L, yeast powder 5~7 g/L. 7. 根据权利要求3-4任一项所述的应用,其特征在于,发酵培养的培养基成分为:大豆蛋白胨 60~100 g/L,甘油 30~60 g/L,酵母粉 0.6~0.8 g/L,K2HPO4·3H2O 0.3-0.6 g/L,MgSO4·7H2O 0.3~0.5 g/L,无水CaCl2 0.0775~0.0975 g/L。7. The application according to any one of claims 3-4, wherein the medium components of the fermentation culture are: soybean peptone 60~100 g/L, glycerol 30~60 g/L, yeast powder 0.6~0.8 g/L, K 2 HPO 4 ·3H 2 O 0.3-0.6 g/L, MgSO 4 ·7H 2 O 0.3-0.5 g/L, anhydrous CaCl 2 0.0775-0.0975 g/L. 8.根据权利要求3所述的应用,其特征在于,在发酵培养基中添加小分子化合物;所述小分子化合物选自丙酮酸、莽草酸、谷氨酸钠。8 . The application according to claim 3 , wherein a small molecule compound is added to the fermentation medium; the small molecule compound is selected from the group consisting of pyruvic acid, shikimic acid, and sodium glutamate. 9 . 9. 根据权利要求8所述的应用,其特征在于,所述小分子化合物添加浓度为丙酮酸2~4g/L、莽草酸2~10 g/L、谷氨酸钠10~15 g/L。9. application according to claim 8, is characterized in that, described small molecule compound addition concentration is pyruvic acid 2~4g/L, shikimic acid 2~10 g/L, sodium glutamate 10~15 g/L . 10. 根据权利要求7~9任一项所述的应用,其特征在于,在发酵培养基中同时添加4 g/L丙酮酸,4 g/L莽草酸和15 g/L谷氨酸钠。10. application according to any one of claim 7~9, is characterized in that, in fermentation medium, add 4 g/L pyruvate simultaneously, 4 g/L shikimic acid and 15 g/L sodium glutamate.
CN202011249346.7A 2020-11-10 2020-11-10 A high-yielding vitamin K2 strain and its application Active CN112175889B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011249346.7A CN112175889B (en) 2020-11-10 2020-11-10 A high-yielding vitamin K2 strain and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011249346.7A CN112175889B (en) 2020-11-10 2020-11-10 A high-yielding vitamin K2 strain and its application

Publications (2)

Publication Number Publication Date
CN112175889A true CN112175889A (en) 2021-01-05
CN112175889B CN112175889B (en) 2022-07-29

Family

ID=73918131

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011249346.7A Active CN112175889B (en) 2020-11-10 2020-11-10 A high-yielding vitamin K2 strain and its application

Country Status (1)

Country Link
CN (1) CN112175889B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104328064A (en) * 2014-09-16 2015-02-04 丽水双健生物工程有限公司 Bacillus natto and application of Bacillus natto in fermentation production of vitamin K2
CN110129234A (en) * 2019-05-27 2019-08-16 沈阳农业大学 Mutagenized Bacillus subtilis strain with high yield of natural vitamin K2 and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104328064A (en) * 2014-09-16 2015-02-04 丽水双健生物工程有限公司 Bacillus natto and application of Bacillus natto in fermentation production of vitamin K2
CN110129234A (en) * 2019-05-27 2019-08-16 沈阳农业大学 Mutagenized Bacillus subtilis strain with high yield of natural vitamin K2 and application thereof

Also Published As

Publication number Publication date
CN112175889B (en) 2022-07-29

Similar Documents

Publication Publication Date Title
CN113564071B (en) Bacillus natto for producing menadione-7 and application thereof
CN101285047A (en) A D-lactic acid producing bacterium with high optical purity and its fermentation process for producing D-lactic acid
CN101173240A (en) A method for producing D-lactic acid and its special-purpose Lactobacillus sporogenes
CN114874941B (en) A Paenibacillus phyllosphere capable of hydrolyzing raw starch and its application
CN102226159B (en) Strain of Enterobacter cloacae and its application in the preparation of 2,3-butylene glycol
CN102268385B (en) Arthrobacter for fermentation production of cyclic adenosine monophosphate and application thereof
CN107475344A (en) A kind of method that vitamin B2 is produced using fermentation of bacillus subtilis
CN110106223B (en) A method for promoting photosynthetic hydrogen production from corn stalks
Yang et al. Production of erythritol from glucose by an osmophilic mutant of Candida magnoliae
CN101619299B (en) Rhodococcus ruber and method for preparing 5-cyanovaleramide by utilizing same
CN114933996A (en) Pit mud synthesized microbiome and preparation and application thereof
CN113122488A (en) Klebsiella engineered bacterium and application thereof in producing glycerol and dihydroxyacetone
CN115637276B (en) Method for producing tetrahydropyrimidine by using halomonas strain
CN102676406B (en) Candida tropicalis for producing ribonucleic acid through fermentation and application thereof
CN101974452B (en) Colimycin high-yield strain and screening method thereof
DK180437B1 (en) Method for Fermentative Production of Oxidized Coenzyme Q10 and High-content Oxidized Coenzyme Q10 Prepared therefrom
CN116333948B (en) Clostridium aerophilum enrichment medium and preparation method thereof
CN116286545B (en) Rhodobacter sphaeroides mutant strain HCYJ-01 and application thereof
CN112175889A (en) A high-yielding vitamin K2 strain and its application
CN116218690A (en) A kind of Curvularia pseudocaritae producing brefeldin A and its fermentation method
CN114790468B (en) MK-7 fermentation production method
CN113136358B (en) An aerobic co-cultivation probiotic fermentation process to increase the production of ginsenosides
CN114686531B (en) Method for preparing 1,3-propanediol by biotransformation
CN105821091A (en) Method for preparing levodopa
CN110878260A (en) Strain for producing D-arabitol and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20230925

Address after: 2nd Floor, Building D6, No. 6 Dongsheng West Road, Jiangyin City, Wuxi City, Jiangsu Province, 214431

Patentee after: Jiangsu Yingyangxing Biotechnology Co.,Ltd.

Address before: 211816 Puzhu South Road, Pukou District, Nanjing, Jiangsu Province, No. 30

Patentee before: Nanjing Tech University